Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enzyme
- PMID: 6548641
- DOI: 10.1021/bi00315a011
Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enzyme
Abstract
Folyl polyglutamate synthetase has been partially purified from mouse liver, and the general features of this enzyme have been characterized. The purification procedure utilized fractionation with ammonium sulfate, gel filtration, and affinity chromatography on ATP-agarose and resulted in a 350-fold increase in specific activity with 8-20% recovery of enzyme activity. Enzyme could be stabilized by glycerol or by ATP, but stability was not appreciably enhanced by folate. The enzymatic reaction was completely dependent on folate, ATP, and Mg2+ while partial reaction rates were observed in the absence of KCl or beta-mercaptoethanol. Highest reaction rates were observed at pH 8.2-9.5 at 37 degrees C. Chromatography of purified enzyme on calibrated gel filtration columns suggested a molecular weight of 65 000. Mouse liver folyl polyglutamate synthetase coupled [3H]glutamic acid to all of the naturally occurring folates studied. Analysis of the reaction products by high-performance liquid chromatography demonstrated that several folyl oligoglutamates were formed at low substrate concentrations but that only folyl diglutamate was formed at substrate concentrations approaching saturation. Dihydrofolate, tetrahydrofolate, 5,10-methylenetetrahydrofolate, 10-formyltetrahydrofolate, and 5-formyltetrahydrofolate were the best substrates. Folic acid and 5-methyltetrahydrofolate were also substrates for this reaction, but much higher concentrations of these compounds were required to saturate the enzyme. These data suggest that all of the tetrahydrofolyl compounds (except 5-methyltetrahydrofolate) are the monoglutamyl substrates for polyglutamation in vivo and that 5-methyltetrahydrofolate is not likely to be a direct precursor for folate polyglutamates in mouse liver.
Similar articles
-
Dual functions of bacteriophage T4D gene 28 product: structural component of the viral tail baseplate central plug and cleavage enzyme for folyl polyglutamates. II. Folate metabolism and polyglutamate cleavage activity of uninfected and infected Escherichia coli cells and bacteriophage.J Virol. 1981 Dec;40(3):645-56. doi: 10.1128/JVI.40.3.645-656.1981. J Virol. 1981. PMID: 7033564 Free PMC article.
-
Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products.J Biol Chem. 1980 Jun 25;255(12):5776-88. J Biol Chem. 1980. PMID: 6892914
-
Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonists.Arch Biochem Biophys. 1987 Aug 1;256(2):585-96. doi: 10.1016/0003-9861(87)90616-3. Arch Biochem Biophys. 1987. PMID: 3619447
-
Gamma-glutamyl hydrolase and drug resistance.Clin Chim Acta. 2006 Dec;374(1-2):25-32. doi: 10.1016/j.cca.2006.05.044. Epub 2006 Jun 10. Clin Chim Acta. 2006. PMID: 16859665 Review.
-
Enzymatic synthesis and function of folylpolyglutamates.Mol Cell Biochem. 1981 Aug 11;38 Spec No(Pt 1):19-48. doi: 10.1007/BF00235686. Mol Cell Biochem. 1981. PMID: 7027025 Review.
Cited by
-
AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferase.Invest New Drugs. 1996;14(3):295-303. doi: 10.1007/BF00194533. Invest New Drugs. 1996. PMID: 8958185
-
Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.Arthritis Rheumatol. 2014 Dec;66(12):3476-85. doi: 10.1002/art.38865. Arthritis Rheumatol. 2014. PMID: 25186097 Free PMC article.
-
Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure.Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9151-5. doi: 10.1073/pnas.89.19.9151. Proc Natl Acad Sci U S A. 1992. PMID: 1409616 Free PMC article.
-
Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide.Cancer Chemother Pharmacol. 1986;17(2):114-20. doi: 10.1007/BF00306738. Cancer Chemother Pharmacol. 1986. PMID: 3719892
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases